EDITORIAL SYNOPSIS It is possible to estimate the vitamin B12 content of liver specimens obtained by needle biopsy. The liver B12 content is not related to the serum levels of vitamin B12, bilirubin, alkaline phosphatase, glutamic-oxaloacetic transaminase, or albumin. It is reduced in a number of pathological conditions of the liver and the reasons for this are discussed, as also are the factors determining the content of B12 in the normal liver.
Vitamin B12 (cyanocobalamin) is normally absorbed, probably by the intrinsic factor mechanism in the lower ileum. It is stored in the liver and from there transported to the bone marrow and other sites for utilization in nuclear maturation. It is excreted in the urine, and to a lesser extent, in the bile (Stokes, 1961) .
Because of difficulty in obtaining human liver for analysis, studies of vitamin B12 storage and deficiency in man have perforce been made chiefly by estimation of serum B12 levels. These studies have been reviewed by Cowling and Mackay (1959) and by Smith (1960) , among others.
The serum vitamin B12 level in health normally lies between 160 and 900 ,ug. per ml., being low in B12 deficiency and raised following parenteral B12 therapy. In both experimental liver injury and clinical liver disease high serum B12 values are not infrequent (Stein, Stein, Aronovitch, Grossowicz, and Rachmilewitz, 1956; Cowling and Mackay, 1959) . They are most often found in diffuse parenchymal cell damage and neoplastic involvement of the liver, and occasionally present in nutritional cirrhosis and active chronic hepatitis. Rarely, the rise may be extreme, as in the patient with 'obstructive hepatic necrosis' reported by Mackay, Cowling, and Gray (1957) , and in some patients with metastatic carcinoma of the liver.
Several factors have been implicated in these changes, but release of stored vitamin B12 from damaged parenchymal cells appears quantitatively most important. There may also be a decrease in hepatic B12 uptake from portal blood (Glass, 1959) , serum, although increased oc-globulins which bind B12 (Pitney, Beard, and Van Loon 1954) are not usual in liver disease. Direct studies of liver B12 content have not been extensive and have been made largely on necropsy material. The reported results vary slightly, depending on methods of extraction and assay of B12. Ross and Mollin (1957) and Pitney and Onesti (1961) both reported higher B12 yields when assay followed papain digestion. Swendseid, Hvolboll, Schick, and Halsted (1957) reported a mean value of 0.70 ,ug. per g. wet liver tissue in 132 necropsy specimens, using L. leishmannii as test organism, while Pitney and Onesti (1961) found a mean value of 0.78 ug. per gram with a range from 0.61 to 1-02 ,ug. per gram wet liver tissue. They used Euiglena gracilis as test organism after preliminary papain digestion. In disease, Girdwood (1952) found negligible amounts of vitamin B12 in the liver of a patient dying with untreated pernicious anaemia. Swendseid and her colleagues (1957) reported a low mean level of 0-26 gg. per g. in necropsy specimens from cirrhotic patients.
Studies of the vitamin B12 content of tissue obtained by needle biopsy of the liver have appeared in recent years. French workers first developed this technique, and demonstrated low liver B12 levels in pernicious anaemia with restoration towards normal following treatment with vitamin B12. In succeeding years, however, few reports dealing with this subject appeared in the literature, possibly because of doubts of the accuracy of an assay necessarily made on a small amount of fragmented tissue. This problem has been resolved by the work of Jhala and Gadgil (1960) and of Pitney and Onesti (1961 The only extensive investigations of liver B12 content using liver biopsy have been those of Nelson and Doctor (1958 , 1962 Vitamin B12 assay was performed after papain digestion using the Z strain of Euglena gracilis (Pitney and Onesti, 1961) . The normal values for this method lie between 0-61 and 1.02 ,g. per g. wet liver tissue. Serum B12 estimations followed the method of Ross (1952) , the normal range for this laboratory being from 160 to 900 jugg. per ml. (Nicholas and Pitney, 1958 The relation between histological diagnosis and liver B12 content is summarized in Table I , and individual results in each group are shown in detail in Figure 1 . The biopsy was histologically normal in 12 cases, but in three later examination disclosed extensive metastatic carcinoma in the liver and these have, therefore, been excluded. The mean and range of the other nine specimens agree closely with those of Pitney and Onesti (1961) , providing further evidence of the validity of bio-assay of small specimens. There was only one low result, 0.39 Mig. per g. in a man of 48 years with megaloblastic anaemia due to nutritional folic acid deficiency. Since his serum B12 was at the lower normal limit, 160 Mug. per ml., it is probable that his diet was also deficient in vitamin B12.
In 12 biopsies the chief histological change was fatty metamorphosis, and the B12 content was below normal in 10 of these with a mean of 0.47 Ag. per g.
In eight of the 12 cases the fatty change was associated with alcoholism and the mean B12 content of these with 0-39 gg. per g. It is possible that two factors are involved, replacement of parenchymal tissue by lipid and inadequate B12 intake due to malnutrition in chronic alcoholics.
Ten biopsies showed only slight to moderate nonspecific parenchymal cell damage without gross
The vitamin B12 content of human liver tissue obtained by aspiration biopsy With the present units this ratio normally lies below 1,500. It is increased if the serum B12 is increased or the liver B12 is reduced, or both. In the patients with normal liver histology this ratio was within the normal range in all except one in whom it was 15,800 due to a high serum B12 level. The ratio was above normal in all patients with viral hepatitis or external biliary obstruction, but in other groups was extremely variable. The results do not suggest that this ratio would be of value in the differential diagnosis of liver disease.
DISCUSSION
The major theoretical difficulties in the use of liver biopsy specimens for bio-assay are the sampling error inherent in using small amounts of tissue, and the reference standard to which the results are referred.
The first of these is the more serious, and it is probable that in patients where liver disease is not diffuse, such as cirrhosis or metastatic neoplasm, occasional anomalous results will be due to this inherent sampling error. The scattering of results in the present series (Fig. 1) Swendseid et al. (1957) and of Pitney and Onesti (1961) determined on necropsy material. They are somewhat higher than those of Drouet, Wolff, Karlin-Weissman, and Rauber (1951) and Jhala and Gadgil (1960) . It is possible that the latter, in India, were dealing with patients whose nutrition was suboptimal. Nelson and Doctor (1958) reported rather higher values from control patients, the mean from 12 subject being 1.94 gg. per g., with a range from 141 to 2.58,ug. per g.The difference may be due to different methods of extraction and assay.
In patients with liver disease, the present mean liver B12 content for patients with portal cirrhosis, 0.43 ,ug. per g., agrees reasonably with the figure of 0.26 ,ug. per g. reported by Swendseid and her colleagues (1957) . In abnormal subjects Nelson and Doctor (1960, 1962) The vitamin B12 content of human liver tissue obtained by aspiration biopsy 235 The combined results of these various investigations allow some general conclusions to be drawn regarding the factors responsible for liver B12 content. Deficiency of vitamin B12 from any cause lowers hepatic B12 stores. This may occur in pernicious anaemia , and to a lesser extent in other states of malnutrition, such as alcoholism, since the results in nutritional cirrhosis were lower than those in haemochromatosis. The low liver B12 content in folic acid deficiency is of interest; it may be nutritional in origin, or, more likely, reflect increased tissue demands for vitamin B12 in the presence of subnormal folic acid supply.
Damage to parenchymal cells seems the most probable cause of the low liver B12 levels usual in viral hepatitis, since the serum B 12 is often increased in the condition. The lack of correlation between lower liver B12 contents and increased serum glutamic-oxaloacetic transaminase levels does not conflict with this, since glutamic-oxaloacetic transaminase is cleared from plasma rapidly (Dunn, Martins, and Reissmann, 1958 ) compared with B12. The raised serum B12 level in some patients with cirrhosis probably also reflects continuing parenchymal cell damage. Nelson and Doctor (1960) suggest that, in addition, hepatic capacity to store B12 may be diminished.
The cause of the low liver B12 content in patients with external biliary obstruction is less certain. It is not an artefact due to the presence of bile components in large amounts in the specimen, for higher levels occur in the cholestatic syndrome, especially when due to causes other than chlorpromazine. Parenchymal cell damage and diminished storage capacity seem likely explanations, but further studies are required for a definite answer.
Replacement of parenchymal cells by tissue unable to store vitamin B12 is also important. This applies to fibrous tissue in cirrhosis, to fatty change in the liver (where malnutrition may also be a factor), and to metastatic neoplasm, where the capacity of the neoplastic cells to store B12 is less than that of normal parenchymal cells (Nelson and Doctor, 1962) . There are, however, several anomalous findings in this situation. Parenchymal tissue without histological neoplastic infiltration has been found in some instances to have a low B12 content (Nelson and Doctor, 1958; present series) . Moreover, there are reports of raised serum B12 levels, often extreme, in patients with various types ofneoplasm irrespective of whether the liver is directly involved (Beard, Pitney, and Sanneman, 1954; Grossowicz, Hochman, Aronovitch, Izak, and Rachmilewitz, 1957; Nelson and Doctor, 1962, present series 
